Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

View More

Pharmaceutical Published Insights

Coherent Market Insights Allergy Treatment Market

Published Date : May 2024

The global allergy treatment market is estimated to be valued at USD 21.19 Bn in 2024 and is expected to exhibit a CAGR of 7.2% during the forecast period (2024-2031). The global allergy treatment market has been witnessing significant growth over the past few years o... View more

Coherent Market Insights Throat Lozenges Market

Published Date : May 2024

Global throat lozenges market is estimated to be valued at USD 4.59 Bn in 2024, and is expected to exhibit a CAGR of 5.8% during the forecast period (2024-2031). Throat lozenges are medicated candies or tablets that are intended to relieve throat irritation and sorene... View more

Coherent Market Insights Contract Pharmaceutical Manufacturing Market

Published Date : May 2024

Global contract pharmaceutical manufacturing market is estimated to be valued at USD 211.34 Bn in 2024, and is expected to exhibit a CAGR of 9.7% during the forecast period (2024-2031). The global contract pharmaceutical manufacturing market has been witnessing steady... View more

Coherent Market Insights Hormone Replacement Therapy Market

Published Date : May 2024

The global hormone replacement therapy market is estimated to be valued at USD 14.89 Bn in 2024 and is expected to exhibit a CAGR of 5.8% during the forecast period (2024-2031). The global hormone replacement therapy market has been witnessing significant growth over ... View more

Coherent Market Insights Temperature Controlled Pharmaceutical Containers Market

Published Date : May 2024

Global temperature controlled pharmaceutical containers market is estimated to be valued at USD 5.09 Bn in 2024, and is expected to exhibit a CAGR of 10.5% during the forecast period (2024-2031). Global temperature controlled pharmaceutical containers market has been ... View more

Coherent Market Insights Acute Bacterial Skin And Skin Structure Infections Absssi Market

Published Date : May 2024

Global acute bacterial skin and skin structure infections market is estimated to be valued at USD  3,842.5 Mn in 2024, and is expected to exhibit a CAGR of 5.8% during the forecast period (2024-2031). Acute bacterial skin and skin structure infections (ABSSSI) re... View more

Coherent Market Insights Medical Composites Market

Published Date : May 2024

The global medical composites market is estimated to be valued at USD 1.23 Bn in 2024 and is expected to exhibit a CAGR of 9.8% during the forecast period (2024-2031). The global medical composites market has witnessed significant growth over the past few years owing ... View more

Coherent Market Insights Joint Pain Injections Market

Published Date : May 2024

The global joint pain injections market is estimated to be valued at USD 5.29 Bn in 2024 and is expected to exhibit a CAGR of 8.7% during the forecast period (2024-2031). The global joint pain injections market has been witnessing steady growth in the past few years. ... View more

Coherent Market Insights Opioids Market

Published Date : May 2024

The U.S. opioids market is estimated to be valued at USD 7.06 Bn in 2024 and is expected to exhibit a CAGR of 3.7% during the forecast period (2024-2031). Opioids are a class of drugs that include prescription pain relievers like oxycodone, hydrocodone, codeine, morph... View more

Coherent Market Insights Actinic Keratosis Market

Published Date : May 2024

The global actinic keratosis market is estimated to be valued at USD 8.73 Bn in 2024 and is expected to exhibit a CAGR of 4.9% during the forecast period (2024-2031). Actinic keratosis is a precancerous skin condition caused by prolonged exposure to UV radiation from ... View more

Coherent Market Insights Allergic Rhinitis Drugs Market

Published Date : Apr 2024

The global allergic rhinitis treatment market is estimated to be valued at USD 16.10 Bn in 2024 and is expected to exhibit a CAGR of 4.8% during the forecast period (2024-2031). Allergic rhinitis, commonly known as hay fever, is a condition where the body exhibits an ... View more

Coherent Market Insights Osteoporosis Treatment Market

Published Date : Apr 2024

 Global osteoporosis treatment market is estimated to be valued at USD 14.91 Bn in 2024, and is expected to exhibit a CAGR of 4.2% during the forecast period (2024-2031). Osteoporosis is a condition characterized by low bone mass and structural deterioration of b... View more

Coherent Market Insights Preventive Vaccines Market

Published Date : Apr 2024

Global preventive vaccines market is estimated to be valued at USD 50.41 Bn in 2024 and is expected to exhibit a CAGR of 9.7% during the forecast period (2024-2031). The global preventive vaccines market is witnessing a period of growth owing to the rising burden of v... View more

Coherent Market Insights Global Tobramycin Eye Drop Market

Published Date : Apr 2024

Global tobramycin eye drop market is estimated to be valued at USD 1,018.9 Mn in 2024 and is expected to exhibit a CAGR of 14.1% during the forecast period (2024-2031). Tobramycin eye drops are topical aminoglycoside antibiotics that are used for treating external eye... View more

Coherent Market Insights Pigmentation Disorders Treatment Market

Published Date : Apr 2024

Global pigmentation disorders treatment market is estimated to be valued at USD 7.33 Bn in 2024 and is expected to exhibit a CAGR of 9.1% during the forecast period (2024-2031). Pigmentation disorders refer to conditions characterized by changes in skin color that are... View more

Coherent Market Insights Animal Healthcare Market

Published Date : Apr 2024

The Europe animal healthcare market is estimated to be valued at USD 15,270.3 Mn in 2024 and is expected to exhibit a CAGR 5.1% during the forecast period (2024-2031). The animal healthcare market in Europe is expected to grow at a significant rate over the next decad... View more

Coherent Market Insights Hemostasis Coagulation Analyzer Market

Published Date : Apr 2024

Global hemostasis/coagulation analyzer market is estimated to be valued at USD 4.36 Bn in 2024 and is expected to exhibit a CAGR of 5.8% during the forecast period (2024-2031). The hemostasis/coagulation analyzer market has been growing at a steady rate over the past ... View more

Coherent Market Insights Animal Growth Promoters Performance Enhancers Market

Published Date : Apr 2024

The global animal growth promoters performance enhancers market is estimated to be valued at USD 17.33 Bn in 2024 and is expected to exhibit a CAGR of 5.9% during the forecast period (2024-2031). Animal growth promoters and performance enhancers refer to feed additive... View more

Coherent Market Insights Us Nasal Spray Market

Published Date : Apr 2024

The U.S. nasal spray market is estimated to be valued at USD 10.42 Bn in 2024, and is expected to exhibit a CAGR of 6.9% during the forecast period (2024-2031). The U.S. nasal spray market has been witnessing steady growth over the past few years due to rising prevale... View more

Coherent Market Insights Intravenous Ibuprofen Market

Published Date : Apr 2024

Global intravenous (IV) ibuprofen market is estimated to be valued at USD 6.91 Bn in 2024 and is expected to exhibit a CAGR of 7% during the forecast period (2024-2031). Intravenous (IV) ibuprofen is used for pain relief and fever reduction for several decades. As an ... View more

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.